Vertex Pharmaceuticals Incorporated Total Non Current Liabilities 2011-2026 | VRTX

Annual Total Non Current Liabilities Vertex Pharmaceuticals Incorporated

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	898 M	690 M	696 M	766 M	899 M	870 M	565 M	1.13 B	846 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.13 B	565 M	818 M

Total Non Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Non Current Liabilities	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	40.2 M	-	2.43 %	$ 254 M	Germany
I-Mab IMAB	131 M	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	4.83 B	-	-	$ 40.3 B	USA
Apellis Pharmaceuticals APLS	289 M	$ 20.13	-2.75 %	$ 2.54 B	USA
Aptorum Group Limited APM	2.21 M	$ 0.8	-4.99 %	$ 4.36 M	China
Biophytis SA BPTS	2.02 M	-	-13.47 %	$ 169 M	France
Axsome Therapeutics AXSM	48.9 M	$ 163.18	-1.92 %	$ 8.12 B	USA
AbCellera Biologics ABCL	326 M	$ 3.64	-4.84 %	$ 1.09 B	Canada
EyeGate Pharmaceuticals, Inc. EYEG	6.39 M	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	110 K	-	-18.52 %	$ 27.3 M	Britain
Adverum Biotechnologies ADVM	27.3 M	-	-	$ 86.2 M	USA
Catalyst Pharmaceuticals CPRX	648 K	$ 23.82	-0.25 %	$ 2.91 B	USA
Институт стволовых клеток человека ISKJ	541 M	-	-	-	Russia
Corvus Pharmaceuticals CRVS	2.31 M	$ 17.04	-4.75 %	$ 818 M	USA
Champions Oncology CSBR	1 M	$ 5.98	-1.48 %	$ 81.7 M	USA
Daré Bioscience DARE	1.39 M	$ 1.59	-1.27 %	$ 13.5 M	USA
DBV Technologies S.A. DBVT	7.14 M	$ 21.94	-5.66 %	$ 2.13 B	France
ARCA biopharma ABIO	409 K	-	1052.0 %	$ 415 M	USA
Acer Therapeutics ACER	244 K	-	2.71 %	$ 14 M	USA
Alpine Immune Sciences ALPN	15.9 M	-	-	$ 2.17 B	USA
Acorda Therapeutics ACOR	257 M	-	-24.86 %	$ 820 K	USA
Capricor Therapeutics CAPR	4.86 M	$ 25.4	-5.44 %	$ 680 M	USA
Eton Pharmaceuticals ETON	4.56 M	$ 17.58	-3.14 %	$ 451 M	USA
Exelixis EXEL	63.6 M	$ 40.7	-0.8 %	$ 11.1 B	USA
Acasti Pharma ACST	12.2 M	-	4.01 %	$ 150 M	Canada
Fennec Pharmaceuticals FENC	30.9 M	$ 7.91	-3.77 %	$ 210 M	USA
Amicus Therapeutics FOLD	245 M	$ 14.35	-0.1 %	$ 4.43 B	USA
Galectin Therapeutics GALT	52 K	$ 2.95	-3.59 %	$ 184 M	USA
CureVac N.V. CVAC	112 M	-	-	$ 867 M	Germany
Aeterna Zentaris AEZS	19.1 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	1.53 M	-	-10.17 %	$ 12.2 K	USA
Galapagos NV GLPG	2.41 B	$ 32.63	-4.28 %	$ 2.69 B	Belgium
Codexis CDXS	28.2 M	$ 0.98	-3.85 %	$ 71.9 M	USA
Greenwich LifeSciences GLSI	9.5 M	$ 26.25	-4.16 %	$ 342 M	USA
Galecto GLTO	541 K	$ 28.88	-3.91 %	$ 767 M	Danmark
Genmab A/S GMAB	769 M	$ 27.42	-7.52 %	$ 17.6 B	Danmark
Aeglea BioTherapeutics AGLE	4.74 M	-	-	$ 1.01 B	USA
Gossamer Bio GOSS	37.2 M	$ 0.44	3.03 %	$ 67.2 M	USA
GeoVax Labs GOVX	14.7 K	$ 1.52	-2.88 %	$ 2.76 M	USA
Grifols, S.A. GRFS	7.22 B	$ 8.51	-6.38 %	$ 6.83 B	Spain
Applied Genetic Technologies Corporation AGTC	4.15 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	2.29 M	-	1.93 %	$ 17.4 M	USA
Agenus AGEN	264 M	$ 3.19	-4.49 %	$ 1.14 M	USA
Ayala Pharmaceuticals AYLA	553 K	-	-	$ 7.46 M	Israel
Halozyme Therapeutics HALO	388 M	$ 68.8	-1.5 %	$ 8.24 B	USA
Akero Therapeutics AKRO	1.52 M	-	-	$ 3.67 B	USA
Agios Pharmaceuticals AGIO	157 M	$ 28.35	-2.91 %	$ 1.64 B	USA
Hoth Therapeutics HOTH	2.71 K	$ 0.98	-3.92 %	$ 6.25 M	USA
Advaxis ADXS	16 M	-	-9.65 %	$ 45.9 M	USA